ClinicalTrials.gg
Status unknownNCT04009694Updated Jul 9, 2019

Does a High BMI Affect Supervised Pelvic Floor Muscle Training for Improving Symptoms in Women With Various Stages of Pelvic Organ Prolapse?

An interventional study of Pelvic Floor Muscle training in Pelvic Organ Prolapse, Uterine Prolapse and Anterior Wall; Prolapse, Vaginal, sponsored by University of Salford. Status unknown at 1 site in United Kingdom. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-09.

Sponsored by University of Salford · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jul 2019), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Sep 2018, registered Jul 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

The trial design is a quasi-experimental cohort trial that includes women referred for pelvic organ prolapse specific physiotherapy.

Candidates will be selected via a convenience sampling method from four physiotherapy outpatient departments at a NHS trust within Greater Manchester. The data collection occurred in January-June 2019 and ethical approval was granted by School Research Ethics, University of Salford.

Treatment aims to ensure there is respect for their autonomy, treatment is fair (Justice), no harm is done to the participant (nonmaleficence) and treatment benefits the participants (beneficence).

Participants are required to complete a consent form prior to their initial session. To ensure methodological quality, the STROBE guidelines will be followed to make certain all apt information required is reported to allow for replication of the intervention.

The trial aims to include (n=60) women with a diagnosed pelvic organ prolapse. They are required to complete 16 weeks of supervised pelvic floor exercises with a specialist physiotherapist as documented within the most recent NICE guidelines.

The outcome measures used will be the Pelvic Organ Prolapse symptom score (POPSS) and this will be documented before and after the 16 week period.

Along side the POPSS, the patients body mass index and severity of pelvic organ prolapse will also be recorded and the results of this will be correlated post trial using the relevant data analysis testing methods.

02

Conditions studied

  • Pelvic Organ Prolapse
  • Uterine Prolapse
  • Anterior Wall; Prolapse, Vaginal
  • Posterior Wall; Prolapse, Vaginal
  • Cystocele
  • Rectocele
  • Vault Prolapse, Vaginal

Keywords

  • Pelvic floor muscle training
  • pelvic physiotherapy
  • pelvic floor exercises
03

In context

Pelvic Organ Prolapse

521 studies on the registry are indexed under Pelvic Organ Prolapse; 80 are open to participants now.

This study's planned enrollment of 60 is below the median of 80 across 336 interventional studies indexed under Pelvic Organ Prolapse.

Browse Pelvic Organ Prolapse studies →

Lead sponsor

University of Salford is the lead sponsor of 27 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Gynaecologist diagnosed women with a mild / moderate or severe pelvic organ prolapse
  • >18 years old

Exclusion criteria

Exclusion Criteria:

  • Unwilling or unable to provide (opt out of treatment)
  • Unable to contract the pelvic floor muscles (determined by the treating physiotherapist)
  • History of Pelvic cancer / or radiotherapy treatment within three months,
  • Neurological or psychiatric disorders,
  • Untreated urinary tract infections,
  • Pregnant or planning to become pregnant or given birth within the past year,
  • Recent vaginal surgery within twelve weeks or evidence of genital oedema,
  • Suspected infection or fragility of the genital area As indicated by the referral source or patient reported at the initial assessment.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Pelvic Floor Muscle Training

    Sixteen weeks of supervised pelvic floor muscle training with a specialist physiotherapist. Participants will be assessed at weeks 0 / 4 / 10 \& 16 and the outcome measures will be recorded at week 0 \& week 16. During each assessment, participants will be educated regarding the anatomy of pelvic organ prolapses and the pelvic floor muscles. They will be taught how to contract their pelvic floor, offered a vaginal examination, given a personalised pelvic floor muscle training programme (including the Knack) - up to a ten second hold long contractions (x 10 repitations) and up to 10 quick contractions. They will also be taught a sub max contraction for up to 30 seconds, offered lifestyle management advice including avoiding heavy lifting or straining. A leaflet explaining the aforementioned information will also be provided at the initial assessment.

    Other: Pelvic Floor Muscle training

Interventions

  • OtherPelvic Floor Muscle training

    Sixteen weeks of supervised pelvic floor muscle training with a specialist physiotherapist

06

What researchers measure

Primary outcomes

  1. Pelvic Organ Prolapse Symptom Score (POPSS)

    The POPSS is a patient-reported Outcome Measure consisting of seven POP symptom specific items, each with a five-point Likert response set (0 = never, 1 = occasionally, 2 = sometimes, 3 = most of the time and 4 = all of the time). The minimum score is 0 which would indicate that the pelvic organ prolapse in a-symptomatic and the maximum score for the POPSS is 28 which would indicate higher severity in pelvic organ prolapse symptoms. In addition, the women select a specific symptom which is most bothersome for them.

    Time frame: sixteen weeks

07

Study locations

1 of 1 sites recruiting
  • National Health Service
    Manchester, M8 5RB, United Kingdom
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2018 (actual). Primary completion is estimated for Sep 2019, 12 months after the start.

Of 162 non-industry interventional studies with no phase under Pelvic Organ Prolapse, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 43. This study's planned 12 months is below that.

Counting every sponsor, half of 179 studies reached it within 23 months; a quarter within 12 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 2, 2019
First posted
Jul 5, 2019
StartActual
Sep 1, 2018
Primary completionEst.
Sep 1, 2019
CompletionEst.
Sep 10, 2019
Last update
Jul 9, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 9, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04009694
Lead sponsor
University of Salford
Responsible party
Rebecca Whittle (Rebecca Whittle BSc Hons. Specialist Pelvic Health Physiotherapist, University of Salford) — Principal investigator
First posted
Jul 5, 2019
Start date
Sep 1, 2018
Primary completion
Sep 1, 2019 (estimated)
Completion
Sep 10, 2019 (estimated)
Last update
Jul 9, 2019

Study contacts

Rebecca C Whittle, MSc
Contact
R.Hadfield1@edu.salford.ac.uk
0161 7202423
Nicky Spence, PhD
Contact
N.Spence@salford.ac.uk
Nicky Spence, PhD
study chair · University of Salford

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion